Jasmin Hundal: AI’s  Significant Impact on Oncology at ASCO 2026
Jasmin Hundal/LinkedIn

Jasmin Hundal: AI’s Significant Impact on Oncology at ASCO 2026

Jasmin Hundal, Chair of Hematology-Oncology Research Fellowship Working Group at Cleveland Clinic, shared a post on LinkedIn:

“It truly feels like a dream come true to be presenting at the American Society of Clinical Oncology (ASCO) Annual Meeting.

Just about two years ago, I became interested in the intersection of artificial intelligence and oncology. At the time, I was excited by the potential but honestly unsure where to even begin. With the guidance of incredible mentors, supportive collaborators, and a willingness to keep exploring, that curiosity gradually turned into opportunities I could have never imagined.

I’m incredibly honored to have been invited to chair and present the session:
Integrating Artificial Intelligence Applications Into Clinical Practice, Cancer Research, and Publishing.” alongside Dr. Caroline Chung and Dr. Hosseini

I will also be speaking on: “The Positive Impact of Artificial Intelligence in Daily Clinical Practice.”

I am especially excited to see how AI will continue to transform cancer care, particularly in breast cancer, from drug discovery and clinical decision-making to improving patient care and outcomes.

AI is already reshaping oncology, from clinical workflows and documentation to research, education, and patient care. I am grateful to contribute to these conversations and continue learning from leaders in this space.

 ASCO Annual Meeting
 Monday |115 pm – 230 PM CT

I hope you can join if this topic interests you!

Looking forward to connecting with colleagues and mentors at ASCO this year.

Here’s a sneak peek at our session.”

Other articles about AI on OncoDaily.